Cardiac troponin I after external electrical cardioversion for atrial fibrillation as a marker of myocardial injury - A preliminary report

Kardiologia Polska

Volumn 65, Issue 6, 2007, Pages 664-669

  Piechota, Wiktor ^a   Gielerak, Grzegorz ^a   Ryczek, Robert ^a   Kaźmierczak, Anna ^a   Bejm, Jolanta ^a   Piechota, Wiesław ^a  

^a MILITARY INSTITUTE OF MEDICINE   (Poland)

Author keywords

Atrial fibrillation; Cardiac troponin I; Cardioversion

Indexed keywords

D DIMER; TROPONIN I;

ADULT; AGED; ARTICLE; CARDIOVERSION; CLINICAL ARTICLE; DEMOGRAPHY; ELECTROCARDIOGRAM; FEMALE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HUMAN; KIDNEY FAILURE; MALE;

EID: 34548383846     PISSN: 00229032     EISSN: 00229032     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Apple FS, Wu AH. Myocardial infarction redefined: role of cardiac troponin testing. Clin Chem 2001; 47: 377-9.
2. Ehsani A, Ewy GA, Sobel BE. Effects of electrical countershock on serum creatine phosphokinase (CPK) isoenzyme activity. Am J Cardiol 1976; 37: 12-8.
3. Santos ES, Pereira MP, Minuzzo L, et al. Electrical cardioversion and myocardial injury: evaluation by new cardiac injury markers. Arq Bras Cardiol 2006; 86: 191-7.
4. Warner ED, Dahl C, Ewy GA. Myocardial injury from transthoracic defibrillator countershock. Arch Pathol 1975; 99: 55-9.
5. Lund M, French JK, Johnson RN, et al. Serum troponins T and I after elective cardioversion. Eur Heart J 2000; 21: 245-53.
6. Gorenek B, Kudaiberdieva G, Goktekin O, et al. Detection of myocardial injury after internal cardioversion for atrial fibrillation. Can J Cardiol 2004; 20: 165-8.
7. Rao AC, Naeem N, John C, et al. Direct current cardioversion does not cause cardiac damage: evidence from cardiac troponin T estimation. Heart 1998; 80: 229-30.
8. Kosior DA, Opolski G, Tadeusiak W, et al. Serum troponin I and myoglobin after monophasic versus biphasic transthoracic shocks for cardioversion of persistent atrial fibrillation. Pacing Clin Electrophysiol 2005; 28 Suppl 1: S128-3
9. Kosior D, Chwyczko T, Stawicki S, et al. Myoglobin and troponin I as markers of myocardial damage during cardioversion of atrial fibrillatio. Pol Arch Med Wewn 2003; 110: 827-36.
10. Schluter T, Baum H, Plewan A, et al. Effects of implantable cardioverter defibrillator implantation and shock application on biochemical markers of myocardial damage. Clin Chem 2001; 47: 459-63.
11. Corell P, Gustafsson F, Kistorp C, et al. Effect of atrial fibrillation on plasma NT-proBNP in chronic heart failure. Int J Cardiol 2007; 117: 395-402.
12. Cemin R, Rauhe W, Marini M, et al. Serum troponin I level after external electrical direct current synchronized cardioversion in patients with normal or reduced ejection fraction: no evidence of myocytes injury. Clin Cardiol 2005; 28: 467-70.
13. Vikenes K, Omvik P, Farstad M, et al. Cardiac biochemical markers after cardioversion of atrial fibrillation or atrial flutter. Am Heart J 2000; 140: 690-6.
14. del Rey Sanchez JM, Hernandez Madrid A, Gonzalez Rebollo JM, et al. External and internal electrical cardioversion: comparative, prospective evaluation of cell damage by means of troponin I. Rev Esp Cardiol 2002; 55: 227-34.
15. Jeremias A, Gibson CM. Narrative review: alternative causes for elevated cardiac troponin levels when acute coronary syndromes are excluded. Ann Intern Med 2005; 142: 786-9.